The efficacy of maternal age screening for Down's syndrome in Wessex

Prenat Diagn. 1991 Jul;11(7):419-25. doi: 10.1002/pd.1970110703.

Abstract

The uptake of amniocentesis in Wessex for the period 1986-1988 was 36 per cent (2873 of 8004 births), a proportion that has not altered significantly since 1984. There is a large difference in uptake between women in the lower risk age group, 35-36 years, and those in the higher risk group, 37+ years, and very considerable differences in uptake among different districts. The prenatal detection over the 3-year study period for women aged 35 or more, after correction for spontaneous loss of Down's syndrome fetuses between prenatal detection and birth, is 53 per cent, a figure that must be inflated due to our failure to ascertain all liveborn Down's syndrome patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Amniocentesis
  • Down Syndrome / diagnosis*
  • Down Syndrome / epidemiology
  • England
  • Female
  • Genetic Testing*
  • Humans
  • Maternal Age*
  • Patient Acceptance of Health Care
  • Pregnancy
  • Retrospective Studies